Rehmann Capital Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.53M | Buy |
161,403
+6
| +0% | +$160 | 0.24% | 73 |
|
|
2025
Q4 | $4.02M | Sell |
161,397
-12,128
| -7% | -$306K | 0.21% | 82 |
|
|
2025
Q3 | $4.41M | Buy |
173,525
+8,623
| +5% | +$213K | 0.24% | 76 |
|
|
2025
Q2 | $4M | Buy |
164,902
+9,695
| +6% | +$226K | 0.24% | 77 |
|
|
2025
Q1 | $3.93M | Sell |
155,207
-9,918
| -6% | -$260K | 0.25% | 81 |
|
|
2024
Q4 | $4.38M | Sell |
165,125
-4,368
| -3% | -$118K | 0.28% | 70 |
|
|
2024
Q3 | $4.93M | Buy |
169,493
+29
| +0% | +$846 | 0.32% | 60 |
|
|
2024
Q2 | $4.74M | Buy |
169,464
+31,883
| +23% | +$878K | 0.34% | 59 |
|
|
2024
Q1 | $3.82M | Buy |
137,581
+3,852
| +3% | +$107K | 0.28% | 70 |
|
|
2023
Q4 | $3.85M | Buy |
133,729
+10,386
| +8% | +$314K | 0.32% | 61 |
|
|
2023
Q3 | $4.09M | Sell |
123,343
-5,911
| -5% | -$209K | 0.38% | 45 |
|
|
2023
Q2 | $4.74M | Buy |
129,254
+18,703
| +17% | +$728K | 0.43% | 41 |
|
|
2023
Q1 | $4.51M | Sell |
110,551
-257
| -0.2% | -$11.1K | 0.42% | 44 |
|
|
2022
Q4 | $5.68M | Sell |
110,808
-836
| -0.7% | -$40.1K | 0.58% | 36 |
|
|
2022
Q3 | $4.89M | Sell |
111,644
-840
| -0.7% | -$40.8K | 0.54% | 35 |
|
|
2022
Q2 | $5.9M | Sell |
112,484
-720
| -0.6% | -$36.7K | 0.65% | 31 |
|
|
2022
Q1 | $5.86M | Sell |
113,204
-6,678
| -6% | -$346K | 0.56% | 33 |
|
|
2021
Q4 | $7.08M | Sell |
119,882
-4,115
| -3% | -$204K | 0.66% | 30 |
|
|
2021
Q3 | $5.34M | Buy |
123,997
+3,553
| +3% | +$157K | 0.51% | 35 |
|
|
2021
Q2 | $4.72M | Buy |
120,444
+772
| +0.6% | +$30K | 0.46% | 41 |
|
|
2021
Q1 | $4.34M | Sell |
119,672
-937
| -0.8% | -$33.3K | 0.44% | 45 |
|
|
2020
Q4 | $4.44M | Sell |
120,609
-4,774
| -4% | -$175K | 0.5% | 35 |
|
|
2020
Q3 | $4.37M | Sell |
125,383
-13,776
| -10% | -$483K | 0.55% | 33 |
|
|
2020
Q2 | $4.32M | Buy |
139,159
+10,499
| +8% | +$357K | 0.59% | 31 |
|
|
2020
Q1 | $3.98M | Buy |
+128,660
| New | +$4.38M | 0.65% | 31 |
|
|
2019
Q3 | $4.38M | Sell |
128,620
-2,051
| -2% | -$74.6K | 0.53% | 24 |
|
|
2019
Q2 | $5.37M | Buy |
130,671
+4,387
| +3% | +$174K | 0.66% | 28 |
|
|
2019
Q1 | $5.09M | Sell |
126,284
-3,542
| -3% | -$142K | 0.69% | 26 |
|
|
2018
Q4 | $5.38M | Sell |
129,826
-2,373
| -2% | -$98.5K | 0.81% | 16 |
|
|
2018
Q3 | $5.53M | Buy |
132,199
+1,854
| +1% | +$71.4K | 0.76% | 24 |
|
|
2018
Q2 | $4.49M | Buy |
130,345
+8,058
| +7% | +$275K | 0.65% | 27 |
|
|
2018
Q1 | $4.12M | Buy |
122,287
+4,002
| +3% | +$138K | 0.64% | 27 |
|
|
2017
Q4 | $4.07M | Sell |
118,285
-2,044
| -2% | -$69.7K | 0.69% | 26 |
|
|
2017
Q3 | $4.08M | Buy |
120,329
+2,693
| +2% | +$86.6K | 0.73% | 25 |
|
|
2017
Q2 | $3.75M | Sell |
117,636
-9,238
| -7% | -$291K | 0.72% | 27 |
|
|
2017
Q1 | $4.12M | Buy |
126,874
+6,685
| +6% | +$211K | 0.69% | 30 |
|
|
2016
Q4 | $3.7M | Buy |
120,189
+3,116
| +3% | +$95.1K | 0.68% | 32 |
|
|
2016
Q3 | $3.76M | Buy |
117,073
+80
| +0.1% | +$2.67K | 0.73% | 33 |
|
|
2016
Q2 | $3.91M | Buy |
116,993
+4,339
| +4% | +$138K | 0.73% | 30 |
|
|
2016
Q1 | $3.17M | Sell |
112,654
-20,088
| -15% | -$574K | 0.62% | 39 |
|
|
2015
Q4 | $4.07M | Buy |
132,742
+1,955
| +1% | +$61.5K | 0.85% | 24 |
|
|
2015
Q3 | $3.9M | Buy |
130,787
+373
| +0.3% | +$12K | 0.88% | 26 |
|
|
2015
Q2 | $4.15M | Buy |
130,414
+5,682
| +5% | +$185K | 0.95% | 22 |
|
|
2015
Q1 | $4.12M | Buy |
124,732
+2,398
| +2% | +$76.2K | 0.93% | 22 |
|
|
2014
Q4 | $3.62M | Sell |
122,334
-3,656
| -3% | -$105K | 0.83% | 26 |
|
|
2014
Q3 | $3.54M | Sell |
125,990
-1,808
| -1% | -$50.7K | 0.84% | 24 |
|
|
2014
Q2 | $3.6M | Buy |
127,798
+1,038
| +0.8% | +$29.6K | 0.86% | 25 |
|
|
2014
Q1 | $3.86M | Buy |
126,760
+3,719
| +3% | +$111K | 1.04% | 19 |
|
|
2013
Q4 | $3.58M | Buy |
123,041
+1,718
| +1% | +$50K | 1.08% | 19 |
|
|
2013
Q3 | $3.31M | Sell |
121,323
-252
| -0.2% | -$6.86K | 1.07% | 25 |
|
|
2013
Q2 | $3.23M | Buy |
+121,575
| New | +$3.36M | 1.12% | 23 |
|
Other funds holding PFE
VCM
VPM
Rehmann Capital Advisory Group's PFE Position: Q1 2026 in Review
Rehmann Capital Advisory Group increased its Pfizer (PFE) stake by 0% in Q1 2026, buying an estimated $160 and bringing the position to 161,403 shares worth $4.53M. The position accounts for 0.24% of the portfolio, ranked #73.
Rehmann Capital Advisory Group first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $7.08M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Rehmann Capital Advisory Group held 161,403 shares of Pfizer worth $4.53M as of Q1 2026.
- Rehmann Capital Advisory Group bought 6 Pfizer shares in Q1 2026, an estimated $160.
- Pfizer made up 0.24% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #73 holding.
- Rehmann Capital Advisory Group first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- Rehmann Capital Advisory Group's Pfizer position peaked at $7.08M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.